miR-103/107 regulates left-right asymmetry in zebrafish by modulating Kupffer's vesicle development and ciliogenesis.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
25 06 2020
Historique:
received: 31 03 2020
accepted: 15 04 2020
pubmed: 27 4 2020
medline: 5 1 2021
entrez: 27 4 2020
Statut: ppublish

Résumé

In zebrafish, cilia movement within the Kupffer's vesicle (KV) generates a fluid flow responsible for accumulating nodal signals exclusively in the left lateral plate mesoderm, thereby initiating left-right patterning (LRP). Defects in LRP cause devastating congenital disorders including congenital heart malformations due to organ mis-positioning. We identified the miR-103/107 family to be involved in regulating LRP. Depletion of miR-103/107 in zebrafish embryos resulted in malpositioned and malformed visceral organs and hearts due to disturbed LRP gene expression, indicating early defects in LRP. Additionally, loss of miR-103/107 affected KV morphogenesis and cilia formation without disturbing endoderm development. Human fibroblasts depleted of miR-103a/107 often failed to extend cilia or developed shorter cilia, indicating functional conservation between species. We identified arl6, araf and foxH1 as direct targets of miR-103/107 providing a mechanistic link to cilia development and nodal signal titration. We describe a new microRNA family controlling KV development and hence influencing establishment of internal organ asymmetry.

Identifiants

pubmed: 32334837
pii: S0006-291X(20)30792-0
doi: 10.1016/j.bbrc.2020.04.066
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

432-439

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no competing interests.

Auteurs

Jana Heigwer (J)

Department of Internal Medicine III, Cardiology, Heidelberg University Hospital, 69120, Heidelberg, Germany and DZHK (German Centre for Cardiovascular Research), Partner Site, Heidelberg, Mannheim, Germany; Department of Pediatrics I, University Children's Hospital Heidelberg, 69120, Heidelberg, Germany. Electronic address: Jana.Heigwer@med.uni-heidelberg.de.

Juliane Kutzner (J)

Department of Internal Medicine III, Cardiology, Heidelberg University Hospital, 69120, Heidelberg, Germany and DZHK (German Centre for Cardiovascular Research), Partner Site, Heidelberg, Mannheim, Germany.

Monika Haeussler (M)

Institute of Biochemistry and Molecular Biology (iBMB), Ulm University, 89081, Ulm, Germany.

Martin D Burkhalter (MD)

Institute of Biochemistry and Molecular Biology (iBMB), Ulm University, 89081, Ulm, Germany; Department of Experimental and Clinical Pharmacology and Pharmacogenomics, University Hospital Tübingen, 72074, Tübingen, Germany.

Thomas Draebing (T)

Department of Internal Medicine III, Cardiology, Heidelberg University Hospital, 69120, Heidelberg, Germany and DZHK (German Centre for Cardiovascular Research), Partner Site, Heidelberg, Mannheim, Germany.

Lonny Juergensen (L)

Department of Internal Medicine III, Cardiology, Heidelberg University Hospital, 69120, Heidelberg, Germany and DZHK (German Centre for Cardiovascular Research), Partner Site, Heidelberg, Mannheim, Germany.

Hugo A Katus (HA)

Department of Internal Medicine III, Cardiology, Heidelberg University Hospital, 69120, Heidelberg, Germany and DZHK (German Centre for Cardiovascular Research), Partner Site, Heidelberg, Mannheim, Germany.

Melanie Philipp (M)

Institute of Biochemistry and Molecular Biology (iBMB), Ulm University, 89081, Ulm, Germany; Department of Experimental and Clinical Pharmacology and Pharmacogenomics, University Hospital Tübingen, 72074, Tübingen, Germany.

Jens H Westhoff (JH)

Department of Pediatrics I, University Children's Hospital Heidelberg, 69120, Heidelberg, Germany.

David Hassel (D)

Department of Internal Medicine III, Cardiology, Heidelberg University Hospital, 69120, Heidelberg, Germany and DZHK (German Centre for Cardiovascular Research), Partner Site, Heidelberg, Mannheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH